Note that some links may require registration or subscription.
The AstraZeneca COVID vaccine’s efficacy is likely more in the range of 69-74%, not 79% as the company originally suggested, an NIH review panel said. (Washington Post)
Experts say that AstraZeneca’s U.S. misstep plus the blood clot scare in Europe could hurt the long-term credibility of its vaccine. (AP)
Why aren’t Johnson & Johnson’s vaccines reaching more people? (Politico)
But things may soon be easing for J&J now that one of its vaccine manufacturing plants has been cleared by regulators. (Reuters)
As of 8:00 a.m. ET Wednesday, the unofficial COVID-19 toll in the U.S. included 29,922,911 cases and 543,849 deaths, up 52,990 and 858, respectively, since this time a day ago.
The European Union is finalizing emergency rules giving it the power to slow exports of COVID-19 vaccines for 6 weeks. (New York Times)
National Guardsmen transporting coronavirus vaccines were stopped at gunpoint by a man claiming to be a detective; he told police he believed that a woman and child were being kidnapped. (NBC News)
Hong Kong suspended use of Pfizer’s COVID-19 vaccine following a report of defective lids on the bottles in one batch. (AP)
Professional athletes and team officials are trying to figure out exactly where in line the athletes should be for vaccinations. (USA Today)
Meanwhile, NBA’s Miami Heat will reserve a section of…
